Cristiano Alessandri Selected Research

Immunoglobulin M (IgM)

7/2022	Lack of cross-reactivity between rheumatoid factor IgM and anti-S1 receptor binding domain of SARS-CoV-2 IgM: a case-control study.
1/2009	Anticitrullinated protein/peptide antibodies and rheumatoid factors: two distinct autoantibody systems.
1/2006	Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cristiano Alessandri Research Topics

Disease

36	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2023 - 01/2004
28	Rheumatoid Arthritis 03/2023 - 01/2004
20	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2022 - 06/2005
17	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 06/2005
8	Inflammation (Inflammations) 02/2021 - 01/2006
7	Arthritis (Polyarthritis) 03/2023 - 01/2009
6	Psoriatic Arthritis 03/2023 - 01/2018
6	Thrombosis (Thrombus) 10/2022 - 06/2005
5	Infections 12/2022 - 01/2004
5	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 10/2010
5	Systemic Scleroderma (Systemic Sclerosis) 05/2008 - 03/2003
4	Lupus Nephritis 04/2021 - 06/2011
4	Rheumatic Diseases (Rheumatism) 10/2018 - 11/2016
4	Psychotic Disorders (Schizoaffective Disorder) 03/2015 - 01/2004
3	COVID-19 07/2022 - 01/2020
3	Necrosis 05/2021 - 07/2017
3	Habitual Abortion (Recurrent Miscarriage) 01/2019 - 10/2010
3	Cognitive Dysfunction 01/2018 - 01/2012
3	Atherosclerosis 01/2017 - 05/2008
3	Mental Disorders (Mental Disorder) 11/2016 - 01/2004
3	Adult-Onset Still's Disease 06/2014 - 04/2011
2	Joint Diseases (Joint Disease) 03/2023 - 01/2004
2	Sjogren's Syndrome (Sjogren Syndrome) 01/2022 - 06/2009
2	Ankylosing Spondylitis 01/2018 - 03/2017
2	Disease Progression 01/2017 - 02/2008
2	Thrombophilia 07/2015 - 01/2014
2	Central Nervous System Lupus Vasculitis 06/2006 - 05/2004
1	Axial Spondyloarthritis 03/2023
1	Fever (Fevers) 11/2022
1	Pregnancy Complications 10/2022
1	Tuberculosis (Tuberculoses) 01/2022
1	Latent Tuberculosis 01/2022
1	Fabry Disease (Fabry's Disease) 04/2021
1	Proteinuria 04/2021
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2021
1	Primary Ovarian Insufficiency 06/2020
1	Osteoarthritis 01/2020

Drug/Important Bio-Agent (IBA)

37	AntibodiesIBA 01/2022 - 03/2003
19	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2005
15	AutoantibodiesIBA 01/2020 - 03/2003
10	Antiphospholipid AntibodiesIBA 10/2022 - 10/2010
7	AutoantigensIBA 10/2022 - 01/2005
7	Biomarkers (Surrogate Marker)IBA 01/2019 - 06/2014
6	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022 - 01/2012
6	CytokinesIBA 05/2021 - 05/2011
5	Rheumatoid FactorIBA 07/2022 - 01/2004
5	Cardiolipins (Cardiolipin)IBA 01/2022 - 10/2010
5	Anti-Citrullinated Protein AntibodiesIBA 01/2020 - 01/2004
5	Peptides (Polypeptides)IBA 11/2018 - 01/2009
4	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2022 - 01/2014
4	VimentinIBA 01/2021 - 10/2010
4	Immunoglobulin G (IgG)IBA 11/2016 - 01/2005
4	Interleukin-18 (Interleukin 18)IBA 06/2014 - 01/2004
3	Immunoglobulin M (IgM)IBA 07/2022 - 01/2006
3	apremilastIBA 07/2021 - 08/2018
3	Estrogen ReceptorsIBA 01/2018 - 03/2012
3	anti-endothelial cell antibodyIBA 03/2015 - 01/2004
2	Adalimumab (Humira)FDA Link 03/2023 - 01/2008
2	Janus Kinase InhibitorsIBA 05/2022 - 01/2022
2	B-Cell Activating FactorIBA 01/2022 - 11/2019
2	belimumabIBA 01/2022 - 07/2020
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2021 - 12/2014
2	Antirheumatic Agents (DMARD)IBA 05/2021 - 01/2020
2	Immunoglobulin A (IgA)IBA 01/2021 - 01/2006
2	Caffeine (No Doz)FDA LinkGeneric 12/2020 - 10/2020
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2020 - 05/2011
2	ImmunosorbentsIBA 01/2020 - 07/2017
2	AntigensIBA 01/2020 - 06/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 02/2008
2	GlucocorticoidsIBA 01/2019 - 07/2017
2	HMGB1 Protein (HMG1)IBA 01/2019 - 01/2017
2	Anti-Idiotypic AntibodiesIBA 01/2018 - 01/2018
2	Estrogens (Estrogen)FDA Link 01/2018 - 01/2016
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2016 - 06/2011
2	cyclic citrullinated peptideIBA 08/2006 - 01/2004
2	SeptinsIBA 06/2006 - 01/2005
1	LectinsIBA 04/2023
1	Biosimilar PharmaceuticalsIBA 03/2023
1	RA 25IBA 03/2023
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2022
1	GTP Phosphohydrolases (GTPases)IBA 11/2022
1	AS 8IBA 09/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	Cell Adhesion MoleculesIBA 01/2022
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	Propidium (Propidium Iodide)IBA 01/2022
1	Lysosomal Membrane ProteinsIBA 01/2022
1	Annexin A5IBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2021
1	Janus KinasesIBA 05/2021
1	baricitinibIBA 05/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 04/2021
1	COVID-19 VaccinesIBA 01/2021
1	Coffee FDA Link 12/2020
1	Messenger RNA (mRNA)IBA 10/2020
1	Ferritins (Ferritin)IBA 07/2020
1	Triptorelin Pamoate (Trelstar)FDA Link 06/2020
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 06/2020

Therapy/Procedure

5	Therapeutics 12/2021 - 01/2008